New study links Pfizer’s new RSV vaccine for pregnant women to preterm births
 |
(NaturalNews) A recently published preprint study adds to the long list of evidence linking Abrysvo, Pfizer’s respiratory syncytial virus (RSV) vaccine for… |
Conspiracy Resource
Conspiracy news & views from all angles, up-to-the-minute and uncensored
Vaccines
Developmental Milestones Among Young Children Declined During COVID Pandemic, Study Finds
A recently published study found significant decreases in communication, problem-solving, and personal-social skills among children up to 5 years of age.
Dr. Meryl Nass: WHO’s pandemic plans are built on lies and misdirection
WHO is not an honest broker, Dr. Meryl Nass told a room of Italian politicians, doctors and nurses. “Its pandemic plans are built on lies and misdirection.” In Rome on Friday, the […]
Read More
Young Kids Nearly 5 Times More Likely to Be Hospitalized With RSV After COVID Pandemic
A new study links the COVID-19 pandemic to a seasonal shift and more severe resurgences of respiratory syncytial virus in children younger than 5.
Massive Rallies Break Out in Japan Against WHO’s Pandemic Treaty. – ‘Don’t Underestimate the Japanese’
“Let’s stop the third atomic bomb with our hands, in the hands of the Japanese people!” April 13, 2024, will be etched in the annals of modern Japanese history as tens of […]
Read More
Scientists Warn Bird Flu Outbreak Could be 100 Times Worse Than COVID. “Weaponized Bird Flu”
All Global Research articles can be read in 51 languages by activating the Translate Website button below the author’s name (only available in desktop version).
To receive Global Research’s Daily Newsletter (selected articles), click here.
Click the share button …
The post Scientists Warn Bird Flu Outbreak Could be 100 Times Worse Than COVID. “Weaponized Bird Flu” appeared first on Global Research.
Read More
Pfizer to Ask for Approval for RSV Vaccine for People as Young as 18
Pfizer on April 9 said it will ask U.S. regulators to approve its respiratory syncytial virus (RSV) vaccine for people as young as 18. The pharmaceutical company said that data from an ongoing phase 3 trial showed the vaccine generated an immune response in people deemed at risk of developing severe illness associated with RSV, […]
